# Genmab (United States)

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/genmab-united-states/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 49 |
| Citations | 43,308 |
| City | Princeton |
| Country | US |
| Description | Genmab (United States) is a research organisation in Princeton, US. OpenAlex records 753 works and 43,308 citations for it. 333 researchers list it as their most recent affiliation. |
| Homepage | http://www.genmab.com/ |
| OpenAlex ID | https://openalex.org/I266595603 |
| Region | New Jersey |
| Researchers | 333 |
| ROR ID | https://ror.org/05258cy55 |
| Type | company |
| Wikidata ID | https://www.wikidata.org/wiki/Q2076526 |
| Works | 753 |

## University papers

- [Impaired IgG-Dependent Anaphylaxis and Arthus Reaction in FcγRIII (CD16) Deficient Mice](https://scholariq.org/papers/impaired-igg-dependent-anaphylaxis-and-arthus-reaction-in-fc-riii-cd16-deficient/)
- [Internal consistency and item-total correlation of patient-reported outcome instruments and hemophilia joint health score v2.1 in US adult people with hemophilia: results from the Pain, Functional Impairment, and Quality of life (P-FiQ) study](https://scholariq.org/papers/internal-consistency-and-item-total-correlation-of-patient-reported-outcome/)
- [Impact of hemophilia B on quality of life in affected men, women, and caregivers—Assessment of patient‐reported outcomes in the B‐<scp>HERO</scp>‐S study](https://scholariq.org/papers/impact-of-hemophilia-b-on-quality-of-life-in-affected-men-women-and-caregivers/)
- [One-year treatment persistence with local estrogen therapy in postmenopausal women diagnosed as having vaginal atrophy](https://scholariq.org/papers/one-year-treatment-persistence-with-local-estrogen-therapy-in-postmenopausal/)
- [Factors associated with pain severity, pain interference, and perception of functional abilities independent of joint status in <scp>US</scp> adults with hemophilia: Multivariable analysis of the Pain, Functional Impairment, and Quality of Life (P‐FiQ) study](https://scholariq.org/papers/factors-associated-with-pain-severity-pain-interference-and-perception-of/)
- [Impact of Sustained Weight Loss on Cardiometabolic Outcomes](https://scholariq.org/papers/impact-of-sustained-weight-loss-on-cardiometabolic-outcomes/)
- [&lt;p&gt;Healthcare Costs of Diabetes and Microvascular and Macrovascular Disease in Individuals with Incident Type 2 Diabetes Mellitus: A Ten-Year Longitudinal Study&lt;/p&gt;](https://scholariq.org/papers/and-lt-p-and-gt-healthcare-costs-of-diabetes-and-microvascular-and-macrovascular/)
- [Associations of weight loss with obesity‐related comorbidities in a large integrated health system](https://scholariq.org/papers/associations-of-weight-loss-with-obesity-related-comorbidities-in-a-large/)
- [Construct validity of patient-reported outcome instruments in US adults with hemophilia: results from the Pain, Functional Impairment, and Quality of life (P-FiQ) study](https://scholariq.org/papers/construct-validity-of-patient-reported-outcome-instruments-in-us-adults-with/)
- [Management of <scp>US</scp> men, women, and children with hemophilia and methods and demographics of the Bridging Hemophilia B Experiences, Results and Opportunities into Solutions (B‐<scp>HERO</scp>‐S) study](https://scholariq.org/papers/management-of-scp-us-scp-men-women-and-children-with-hemophilia-and-methods-and/)
- [Cost-effectiveness and budget impact of liraglutide in type 2 diabetes patients with elevated cardiovascular risk: a US-managed care perspective](https://scholariq.org/papers/cost-effectiveness-and-budget-impact-of-liraglutide-in-type-2-diabetes-patients/)
- [Incremental health care resource utilization and expenditures associated with autosomal dominant polycystic kidney disease](https://scholariq.org/papers/incremental-health-care-resource-utilization-and-expenditures-associated-with/)

## University researchers

- [Neeraj N. Iyer](https://scholariq.org/researchers/neeraj-n-iyer/)

## University top topics

Showing 8 of 25.

- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.